PF-514273

PF-514273 is a drug that was developed by Pfizer for the treatment of hypertension (high blood pressure). It works by blocking the action of a hormone called aldosterone, which is known to increase blood pressure. PF-514273 is a selective mineralocorticoid receptor antagonist, meaning it specifically targets and blocks the mineralocorticoid receptor, thereby reducing the effects of aldosterone.

Mechanism of Action

PF-514273 works by blocking the mineralocorticoid receptor, a protein found in cells that aldosterone binds to. When aldosterone binds to the mineralocorticoid receptor, it causes the body to retain sodium and water, which increases blood volume and blood pressure. By blocking the mineralocorticoid receptor, PF-514273 prevents aldosterone from having this effect, thereby reducing blood pressure.

Clinical Trials

PF-514273 has undergone clinical trials to assess its safety and efficacy in treating hypertension. In these trials, it was found to be effective in reducing blood pressure and was well-tolerated by patients. However, further research is needed to fully understand the long-term effects and potential benefits of this drug.

Side Effects

As with any drug, PF-514273 can cause side effects. These may include dizziness, nausea, and fatigue. If you experience any of these side effects while taking PF-514273, you should contact your healthcare provider immediately.

See Also

• Hypertension
• Aldosterone
• Mineralocorticoid receptor
• Clinical trials

PF-514273 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia